CT Image Analysis Software - CT Cerebral CTA

United Imaging Intelligence
The CT Cerebral CTA application is intended to assist in detecting and evaluating aneurysms for head and neck CTA images.
CT Cerebral CTA
Information source: Vendor
Last updated: April 30, 2025

General Information

General
Product name CT Image Analysis Software - CT Cerebral CTA
Company United Imaging Intelligence
Subspeciality Neuro
Modality CT
Disease targeted Aneurysm
Key-features Reconstructed images (MPR/VR/MIP/Probe/CPR/SCPR), segmentation of bones and arteries of the head and neck, detection of aneurysms, radiology report
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps),
During: interactive decision support (shows abnormalities/results only on demand),
During: report suggestion

Technical Specifications

Data characteristics
Population Adult patients (18–120 years). Contraindications are the same as for Head and Neck CTA, including iodine allergy, asthma, renal insufficiency, severe cardiovascular disease, and cachexia. Use with caution in case of: 1. Moyamoya disease or brain tumors. 2. Vascular malformations or extreme tortuosity of head/neck vessels. 3. Prior cerebrovascular surgery (e.g., stents, embolization, clipping). 4. Poor image quality due to noise, motion, or metal artifacts (e.g., stents, dentures).
Input CTA
Input format DICOM
Output Reconstructed images (MPR/VR/MIP/Probe/CPR/SCPR), segmentation of bones and arteries of the head and neck, detection of aneurysms, draft radiology report
Output format
Technology
Integration Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time

Regulatory

Certification
CE
Certified, Class IIa , MDR
FDA 510(k) cleared
Intended Use Statements
Intended use (according to CE) The CT Cerebral CTA application is intended to assist in detecting and evaluating aneurysms for head and neck CTA images.

Market

Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, subscription, one-time license fee
Based on Number of users, number of installations, number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers